SARTORE BIANCHI, ANDREA

SARTORE BIANCHI, ANDREA  

Dipartimento di Oncologia ed Emato-Oncologia  

Risultati 1 - 20 di 159 (tempo di esecuzione: 0.003 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 1-gen-2016 E. ValtortaF. PietrantonioS. SienaA. Sartore-Bianchi + Article (author) -
Acquired resistance to EGFR-targeted therapies incolorectal cancer 1-set-2014 A. Sartore BianchiS. Siena + Article (author) -
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 1-gen-2016 A. Sartore BianchiS. Siena + Article (author) -
Adaptive mutability of colorectal cancers in response to targeted therapies 20-dic-2019 Sartore-Bianchi, AndreaSiena, SalvatoreGherardi, MarcoLagomarsino, Marco Cosentino + Article (author) -
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer 1-gen-2021 Manca P.Sartore Bianchi A.Randon G.Prisciandaro M.Pietrantonio F. + Article (author) -
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer 1-dic-2017 F. PietrantonioA. Sartore-BianchiG. FucàS. SienaF. de Braud + Article (author) -
The Amount of Evidence Needed to Support ERBB2 as a Biomarker for Resistance to EGFR Inhibitors in Metastatic Colorectal Cancer 1-gen-2019 Sartore-Bianchi, AndreaSiena, Salvatore + Article (author) -
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer 1-giu-2013 E. ValtortaA. Sartore BianchiG. MigliardiS. Siena + Article (author) -
Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer 1-gen-2006 A. Sartore BianchiM. MoroniS. Siena + Article (author) -
Aspirin for colorectal cancer with PIK3CA mutations : the rising of the oldest targeted therapy? 1-lug-2013 A. Sartore BianchiS. Siena + Article (author) -
Assessment of a HER2 scoring system for colorectal cancer : results from a validation study 1-nov-2015 A. Sartore BianchiG. VialeS. Siena + Article (author) -
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab 1-gen-2010 A. Sartore-BianchiS. Siena + Article (author) -
Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer 1-ott-2009 S. SienaSARTORE BIANCHI, ANDREA + Article (author) -
Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to Anti-EGFR therapies in colorectal cancer 19-feb-2014 A. Sartore BianchiE. ValtortaS. Siena + Article (author) -
Bortezomib inhibits nuclear factor-κB-dependent survival and has potent in vivo activity in mesothelioma 1-ott-2007 Sartore-Bianchi, Andrea + Article (author) -
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis 1-gen-2015 A. Sartore BianchiS. SienaF. De BraudF. Pietrantonio + Article (author) -
Breaking Barriers in HER2+ Cancers 27-ago-2020 Siena, SalvatoreSartore-Bianchi, Andrea + Article (author) -
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 1-gen-2019 Pietrantonio, FilippoLobefaro, RiccardoRaimondi, AlessandraSartore-Bianchi, AndreaLongarini, RaffaellaPetrelli, FaustoRandon, GiovanniPagani, FilippoFucà, Giovannide Braud, Filippo + Article (author) -
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions 1-set-2020 Pani, AriannaSartore-Bianchi, AndreaSiena, SalvatoreScaglione, Francesco + Article (author) -
Central Nervous System as Possible Site of Relapse in ERBB2-PositiveMetastatic Colorectal Cancer:Long-term Results of TreatmentWith Trastuzumab and Lapatinib 1-mar-2020 A. Sartore BianchiS. Siena + Article (author) -